Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microdacyn for prevention of intra-operative wound contamination in clean surgery
ACTRN12616001391460Phase 4Not yet recruiting
- Sponsor
- Richard Everts
- Start
- Nov 2016
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hypochlorous acid in surgical site infection (SSI) (4 arms), sponsored by Richard Everts. Primary endpoint: Bacterial contamination of intra-operative wound swabs. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
hypochlorous acid
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on ACTRN12616001391460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001391460.